Resting CD4+ T lymphocytes but not thymocytes provide a latent viral reservoir in a simian immunodeficiency virus-Macaca nemestrina model of human immunodeficiency virus type 1-infected patients on highly active antiretroviral therapy.
about
IL-15 induces CD4 effector memory T cell production and tissue emigration in nonhuman primatesLatency: the hidden HIV-1 challenge.Animal Models for HIV Cure ResearchConsiderations in the development of nonhuman primate models of combination antiretroviral therapy for studies of AIDS virus suppression, residual virus, and curative strategiesRecent developments in human immunodeficiency virus-1 latency researchPersistence of viral reservoirs in multiple tissues after antiretroviral therapy suppression in a macaque RT-SHIV modelUsing animal models to overcome temporal, spatial and combinatorial challenges in HIV persistence researchControl of viremia and prevention of AIDS following immunotherapy of SIV-infected macaques with peptide-pulsed bloodAn "escape clock" for estimating the turnover of SIV DNA in resting CD4⁺ T cellsRecent advances on the use of structural biology for the design of novel envelope immunogens of HIV-1Therapy for persistent HIV.Eradication therapies for HIV Infection: time to begin again.Coordinated regulation of SIV replication and immune responses in the CNS.Viral decay kinetics in the highly active antiretroviral therapy-treated rhesus macaque model of AIDS.Viral sanctuaries during highly active antiretroviral therapy in a nonhuman primate model for AIDSSuppression of virus load by highly active antiretroviral therapy in rhesus macaques infected with a recombinant simian immunodeficiency virus containing reverse transcriptase from human immunodeficiency virus type 1.The molecular biology of HIV latency: breaking and restoring the Tat-dependent transcriptional circuit.Plasmodium infection reduces the volume of the viral reservoir in SIV-infected rhesus macaques receiving antiretroviral therapyA simian immunodeficiency virus-infected macaque model to study viral reservoirs that persist during highly active antiretroviral therapy.Profound early control of highly pathogenic SIV by an effector memory T-cell vaccine.Analysis of multiply spliced transcripts in lymphoid tissue reservoirs of rhesus macaques infected with RT-SHIV during HAARTReplication-competent simian immunodeficiency virus (SIV) Gag escape mutations archived in latent reservoirs during antiretroviral treatment of SIV-infected macaques.Eradicating HIV-1 infection: seeking to clear a persistent pathogen.Paucity of CD4+CCR5+ T cells is a typical feature of natural SIV hosts.Simian Immunodeficiency Virus SIVsab Infection of Rhesus Macaques as a Model of Complete Immunological Suppression with Persistent Reservoirs of Replication-Competent Virus: Implications for Cure Research.Latent HIV-1 infection of resting CD4⁺ T cells in the humanized Rag2⁻/⁻ γc⁻/⁻ mouseGeneration of HIV latency in humanized BLT mice.Accumulation of Cytotoxic CD16+ NK Cells in Simian Immunodeficiency Virus-Infected Lymph Nodes Associated with In Situ Differentiation and Functional Anergy.Progressive CD4+ central memory T cell decline results in CD4+ effector memory insufficiency and overt disease in chronic SIV infectionRegulatory T-cell markers, indoleamine 2,3-dioxygenase, and virus levels in spleen and gut during progressive simian immunodeficiency virus infection.Suppression of viremia and evolution of human immunodeficiency virus type 1 drug resistance in a macaque model for antiretroviral therapy.Interleukin-21 combined with ART reduces inflammation and viral reservoir in SIV-infected macaquesUse of a small molecule CCR5 inhibitor in macaques to treat simian immunodeficiency virus infection or prevent simian-human immunodeficiency virus infection.Characterization of peripheral and mucosal immune responses in rhesus macaques on long-term tenofovir and emtricitabine combination antiretroviral therapy.Experimental approaches to the study of HIV-1 latency.HIV reservoirs and latency models.Regulation of HIV-1 latency by T-cell activation.Tissue reservoirs of HIVLong-term vaccine protection from AIDS and clearance of viral DNA following SHIV89.6P challenge.SIV replication is directly downregulated by four antiviral miRNAs.
P2860
Q24547172-32F010AF-098A-43EB-8F10-5DF58D92B464Q25255905-D94EECAA-BF0C-420F-8DE4-AE71F4360F05Q26767476-E462887A-CE1E-4544-87C3-9766A3422DE0Q26825814-E1414DEA-C898-4810-A9A7-93DADA539AF1Q27013114-CBD59090-FC11-4D43-BC98-9BEACD133314Q27335485-1B9216BB-F942-4B40-9B3C-86B5A5C27F17Q28077662-44A528E1-B30C-4AD2-9471-312C0175E220Q28472597-1115D938-0FAC-4B6D-9F19-AAC580A4A32EQ28482134-6ADCD4CE-E701-40E5-B4BB-429D9E70CB19Q30353580-BF78F6B7-5536-43E3-8450-9089DF44E425Q30386370-2377BF25-C0C7-4647-A959-D0E6B89B35BAQ30399588-549A92CD-2A58-48DD-96D1-A08EF4F44B91Q33519523-1045BC38-7C9A-4489-ABBF-660B65DEA1E2Q33644248-813512ED-1555-4D3D-BEC8-758FEE28E5DFQ33676630-DF3B1C82-EC2E-482A-808E-E8A259E80213Q33843148-FC72A308-3DC6-46A3-B12F-FB6B867F9EB6Q34544409-919C50A6-CE36-4CF6-AFC2-F349761F335DQ34722464-A932D073-251B-453B-8CA6-D1EF551B7E6FQ34990151-F0B6856D-F948-476A-A592-5C7D5A8F67A7Q35009558-B5CB4643-3881-49A1-B63C-23C91C6392B6Q35088292-B2BDF29C-E591-439C-8D09-5C7600C1B949Q35192975-948FEB7F-A973-4B31-BFF8-9309790E12A8Q35252186-4608878F-942A-48DC-BCE2-8504660FACCAQ35616028-76D4A72E-B328-444F-841C-909FB723E5F9Q35641175-872EF7B9-1518-4C5C-BF83-3503C6A850E3Q35665924-8382EAD2-7109-4844-8FEE-6F567735D4FFQ35666126-37F8DD96-5F26-4900-BFE0-E93116880A77Q35745406-BCA553C2-C2FC-4C1A-BCD0-0CBAB2E01417Q36229666-9BCE3A5D-3661-466C-9178-B421DEB0F9E7Q36315049-84AED39E-FBE4-48F5-802F-F36905B7DAD3Q36315555-0FFF87B2-F561-4C5E-919A-0BAC01316894Q36335882-AC096E19-12D5-4487-A4A9-53D607FAF1C8Q36371505-89EEEAD2-99E3-4F5A-888F-71279E4E86CAQ36389032-31AE39D4-C62D-4BC8-B0A1-761031948769Q36708954-9FFAD5FF-0488-4904-904A-1277FCD753FCQ36746403-0AB92092-4012-43FD-9B62-F0704A133DFEQ36887625-F299AF88-1092-41A8-9315-4FAA7B129A31Q37055454-5FA9684E-E340-4470-96E4-DD46B233EA81Q37141704-BEB859C0-A0AC-4E95-B45A-682932D06DC8Q37155048-64BEBFC8-F32E-418F-879A-8AE4E04CD841
P2860
Resting CD4+ T lymphocytes but not thymocytes provide a latent viral reservoir in a simian immunodeficiency virus-Macaca nemestrina model of human immunodeficiency virus type 1-infected patients on highly active antiretroviral therapy.
description
2003 nî lūn-bûn
@nan
2003 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Resting CD4+ T lymphocytes but ...... active antiretroviral therapy.
@ast
Resting CD4+ T lymphocytes but ...... active antiretroviral therapy.
@en
Resting CD4+ T lymphocytes but ...... active antiretroviral therapy.
@nl
type
label
Resting CD4+ T lymphocytes but ...... active antiretroviral therapy.
@ast
Resting CD4+ T lymphocytes but ...... active antiretroviral therapy.
@en
Resting CD4+ T lymphocytes but ...... active antiretroviral therapy.
@nl
prefLabel
Resting CD4+ T lymphocytes but ...... active antiretroviral therapy.
@ast
Resting CD4+ T lymphocytes but ...... active antiretroviral therapy.
@en
Resting CD4+ T lymphocytes but ...... active antiretroviral therapy.
@nl
P2093
P2860
P921
P1433
P1476
Resting CD4+ T lymphocytes but ...... active antiretroviral therapy.
@en
P2093
Anding Shen
Janice E Clements
Joseph L Mankowski
Karen Chadwick
Lucy M Carruth
M Christine Zink
P2860
P304
P356
10.1128/JVI.77.8.4938-4949.2003
P407
P577
2003-04-01T00:00:00Z